Azacitidine
Showing 551 - 575 of 685
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in
Completed
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +11 more
- decitabine
- +9 more
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Nov 13, 2019
Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin Trial in Lexington (Azacitidine with rituximab, vincristine, and
Completed
- Lymphoma
- +2 more
- Azacitidine with rituximab, vincristine, and cyclophosphamide
-
Lexington, KentuckyUniversity of Kentucky
Oct 13, 2016
Chronic Myelomonocytic Leukemia, de Novo MDS, MDS Trial in Cleveland (other, drug, genetic)
Completed
- Chronic Myelomonocytic Leukemia
- +7 more
- flow cytometry
- +7 more
-
Cleveland, Ohio
- +1 more
Feb 21, 2019
MDS Trial in Italy (5-Azacytidine, Valproic Acid, ATRA)
Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial in
Terminated
- Stage IA Non-Small Cell Lung Carcinoma
- +4 more
- Azacitidine
- +4 more
-
Lexington, Kentucky
- +2 more
Nov 17, 2016
Myelodysplastic Syndrome Trial in New York (Tosedostat)
Completed
- Myelodysplastic Syndrome
-
New York, New YorkWeill Cornell Medical College
Jun 7, 2018
Acute Myeloid Leukemia Trial in Worldwide (Azacitidine, Conventional Care Regimen)
Completed
- Acute Myeloid Leukemia
- Azacitidine
- Conventional Care Regimen
-
Boston, Massachusetts
- +111 more
Aug 25, 2017
Recurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer Trial in Aurora, Columbus,
Follicular Lymphoma, Marginal Zone Lymphoma Trial in Durham (azacitidine, lenalidomide)
Terminated
- Follicular Lymphoma
- Marginal Zone Lymphoma
- azacitidine
- lenalidomide
-
Durham, North CarolinaDuke University Medical Center
Aug 1, 2016
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Pittsburgh (5-azacytidine (5-aza) maintenance therapy
Withdrawn
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- 5-azacytidine (5-aza) maintenance therapy after transplant
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Mar 29, 2018
Prostate Cancer, Pain Trial in Miami (Azacitidine, Docetaxel, Prednisone)
Terminated
- Prostate Cancer
- Pain
- Azacitidine
- +5 more
-
Miami, FloridaUniversity of Miami Sylvester Comprehensive Cancer Center
May 3, 2016
Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults, AML (Adult) With 11q23
Terminated
- Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults
- +7 more
-
Stanford, CaliforniaStanford University School of Medicine
Sep 25, 2018
Chronic Myelomonocytic Leukemia Trial in Buffalo, Portland, Salt Lake City (5-Azacitidine)
Completed
- Chronic Myelomonocytic Leukemia
-
Buffalo, New York
- +2 more
May 10, 2016
Leukemia Trial in Houston (Azacitidine, Sorafenib)
Chronic Myelomonocytic Leukemia-2, Myelodysplastic Syndrome, Myeloproliferative Tumor Trial in United States (Cytarabine,
Completed
- Chronic Myelomonocytic Leukemia-2
- +3 more
- Cytarabine
- +2 more
-
Bozeman, Montana
- +8 more
Apr 11, 2018
SMD Trial in France (ACADESINE 140mg/kg/d, ACADESINE 210mg/kg/d, ACADESINE 315mg/kg/d)
Terminated
- SMD
- ACADESINE 140mg/kg/d
- +2 more
-
Bayonne, France
- +16 more
Nov 7, 2016